Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Diabetes Res Clin Pract. 2010 Mar 7;89(1):88–93. doi: 10.1016/j.diabres.2010.02.013

Table 3.

Estimated prevalence of latent classes and the probability of observed metabolic syndrome features for each class. All observed variables are dichotomous as defined in Table 1. Models include either a measure of central adiposity or fasting insulin.

Latent Classes 1 2 3
Model
A Latent factor 0.38 0.18 0.44
Hypertension 0.00 0.85 0.69
Dyslipidemia 0.20 0.003 0.55
Hyperglycemia 0.26 0.51 0.71
Waist circumference 0.13 0.00 0.67
B
Latent Factor 0.47 0.12 0.41
Hypertension 0.07 1.00 0.73
Dyslipidemia 0.22 0.00 0.52
Hyperglycemia 0.29 0.55 0.73
IAF 0.00 0.00 0.61
C
Latent Factor 0.58 0.25 0.17
Hypertension 0.26 0.86 0.49
Dyslipidemia 0.19 0.37 0.67
Hyperglycemia 0.29 0.89 0.66
Fasting insulin 0.09 0.24 0.91